Dr Lal PathLabs Q4 FY26 Revenue Up 16.6% YoY

Dr Lal PathLabs reported Q4 FY26 revenue of ₹703 crore, a 16.6% YoY growth driven by 12.9% sample volume increase.
Full-year FY26 revenue grew 12.2% with normalized EBITDA of ₹783 crore and normalized PAT of ₹532 crore, reflecting strong operational performance.
The company expanded its network by adding 14 new labs and over 1100 collection centers in FY26, enhancing its pan-India presence.
Management highlighted strategic initiatives including the launch of AI-powered wellness brand Sovaaka and hosting the Medllumina international medical conference.